SABRIL

Drug Lundbeck LLC
Total Payments
$22.8M
Transactions
766
Doctors
449
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $684,750 4 2
2023 $1.3M 4 2
2022 $1.8M 9 7
2021 $2.0M 7 5
2020 $5.7M 6 3
2019 $2.9M 6 4
2018 $4.1M 8 6
2017 $4.4M 722 434

Payments by Nature

Nature of Payment Amount Transactions Share
Royalty or License $19.3M 32 84.5%
Unspecified $3.5M 1 15.3%
Honoraria $19,600 121 0.1%
Food and Beverage $9,661 605 0.0%
Travel and Lodging $1,873 4 0.0%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,440 2 0.0%
Consulting Fee $528.50 1 0.0%

Payments by Type

General
$19.3M
765 transactions
Research
$3.5M
1 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Preventing Epilepsy using Vigabatrin in Infants with TB Complex (PREVENT Trial), a randomized, double-blind, placebo controlled seizure prevention clinical trial for infants with TSC Lundbeck LLC $3.5M 0

Top Doctors Receiving Payments for SABRIL — Page 6

Doctor Specialty Location Total Records
, MD Neurology Austell, GA $122.30 7
, MD, PHD Neurodevelopmental Disabilities Orange, CA $107.02 5
, MD Neurology with Special Qualifications in Child Neurology San Diego, CA $104.36 5
, M.D Pediatrics Long Beach, CA $104.20 6
, M.D Neurology with Special Qualifications in Child Neurology Minneapolis, MN $103.79 5
, M.D Specialist Monroe, LA $101.82 6
, M.D Neurology with Special Qualifications in Child Neurology Plano, TX $94.36 5
, M.D Neurology with Special Qualifications in Child Neurology Plano, TX $94.36 5
, M.D Neurology with Special Qualifications in Child Neurology San Diego, CA $81.22 4
, MD PHD Neurology San Diego, CA $80.79 4
, M.D Neurology with Special Qualifications in Child Neurology Macon, GA $80.62 5
, M.D Neuromuscular Medicine San Diego, CA $78.71 4
, M.D Pediatrics Orange, CA $75.12 4
, MD Neurology New York, NY $73.10 4
, MD Epilepsy Plano, TX $72.27 4
, D.O Neurology Saint Marys, OH $66.54 8
, M.D Neurology Dublin, OH $61.29 8
Michele Kleiman Specialist Middletown, CT $59.47 4
, M.D Neurology with Special Qualifications in Child Neurology San Diego, CA $59.41 3
, M.D Neurology with Special Qualifications in Child Neurology Plano, TX $56.23 3
, MD Neurology with Special Qualifications in Child Neurology Plano, TX $54.98 3
, MD Neurology with Special Qualifications in Child Neurology Riverton, UT $54.03 5
, M.D Neurology Upper Arlington, OH $53.18 5
, M.D Neurology Rocklin, CA $52.95 4
, DO Neurology with Special Qualifications in Child Neurology Henderson, NV $52.85 3

About SABRIL

SABRIL is a drug associated with $22.8M in payments to 449 healthcare providers, recorded across 766 transactions in the CMS Open Payments database. The primary manufacturer is Lundbeck LLC.

Payment data is available from 2017 to 2024. In 2024, $684,750 was paid across 4 transactions to 2 doctors.

The most common payment nature for SABRIL is "Royalty or License" ($19.3M, 84.5% of total).

SABRIL is associated with 1 research study, including "Preventing Epilepsy using Vigabatrin in Infants with TB Complex (PREVENT Trial), a randomized, double-blind, placebo controlled seizure prevention clinical trial for infants with TSC" ($3.5M).